Pharmaceutical Supply – Albendazole Tablets (200 mg)

The contract pertains to the supply of FDA-approved Albendazole Tablets, 200 mg, packaged in bottles containing two tablets each, with all components adhering to USP standards for quality and consistency. The supplier is responsible for complete packaging and labeling compliance, ensuring the product meets federal regulatory requirements for distribution within the United States. Delivery must be completed within five days of order placement, emphasizing urgent turnaround and reliable logistics to support medical needs. The procurement is issued under a subcontract classification by the Department of Defense through the Medical Supply Chain Pharm FSA, with the place of performance designated at Fort Lewis, WA, 98433-9500. The solicitation was posted on July 29, 2026, and responses are due by August 4, 2026, indicating a tight turnaround window for bids. The NAICS code 325412 confirms the focus on pharmaceutical and medicinal product manufacturing, and the contract is part of a broader defense medical supply initiative requiring strict adherence to timelines, regulatory compliance, and packaging specifications.